Ghent University Academic Bibliography

Advanced

Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study

G Salles, J Catalano, P Feugier, Fritz Offner UGent, R Bouabdallah, D Caballero, P Brice, LM Pedersen, C Haioun, D Belada, et al. (2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(suppl. 2). p.229-229
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
Haematol-Hematol. J.
volume
95
issue
suppl. 2
pages
229 - 229
conference name
15th Annual meeting of the European Hematology Association
conference location
Barcelona, Spain
conference start
2010-06-10
conference end
2010-06-13
Web of Science type
Meeting Abstract
Web of Science id
000279051300557
JCR category
HEMATOLOGY
JCR impact factor
6.532 (2010)
JCR rank
7/65 (2010)
JCR quartile
1 (2010)
ISSN
0390-6078
language
English
UGent publication?
yes
classification
C3
id
2119653
handle
http://hdl.handle.net/1854/LU-2119653
date created
2012-05-30 09:47:38
date last changed
2016-12-19 15:36:40
@inproceedings{2119653,
  author       = {Salles, G and Catalano, J and Feugier, P and Offner, Fritz and Bouabdallah, R and Caballero, D and Brice, P and Pedersen, LM and Haioun, C and Belada, D and Delmer, A and Simpson, D and Tilly, H and Leppa, S and Soubeyran, P and Hagenbeek, A and Casasnovas, O and Tanin, I and Ferme, C and Da Silva, MG and Sebban, C and Pettengell, R and Estell, J and Milone, G and Sonnet, A and Lopez-Guillermo, A and Seymour, J and Xerri, L},
  booktitle    = {HAEMATOLOGICA-THE HEMATOLOGY JOURNAL},
  issn         = {0390-6078},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl. 2},
  pages        = {229--229},
  title        = {Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study},
  volume       = {95},
  year         = {2010},
}

Chicago
Salles, G, J Catalano, P Feugier, Fritz Offner, R Bouabdallah, D Caballero, P Brice, et al. 2010. “Rituximab Maintenance for 2-years Significantly Improves the Outcome of Patients with Untreated High Tumor Burden Follicular Lymphoma After Response to Immunochemotherapy: Results of the PRIMA Study.” In Haematologica-the Hematology Journal, 95:229–229.
APA
Salles, G, Catalano, J., Feugier, P., Offner, F., Bouabdallah, R., Caballero, D., Brice, P., et al. (2010). Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (Vol. 95, pp. 229–229). Presented at the 15th Annual meeting of the European Hematology Association.
Vancouver
1.
Salles G, Catalano J, Feugier P, Offner F, Bouabdallah R, Caballero D, et al. Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2010. p. 229–229.
MLA
Salles, G, J Catalano, P Feugier, et al. “Rituximab Maintenance for 2-years Significantly Improves the Outcome of Patients with Untreated High Tumor Burden Follicular Lymphoma After Response to Immunochemotherapy: Results of the PRIMA Study.” Haematologica-the Hematology Journal. Vol. 95. 2010. 229–229. Print.